HTGC - Hercules Capital, Inc.

NYSE - NYSE Delayed Price. Currency in USD
11.47
-0.04 (-0.35%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous close11.51
Open11.60
Bid0.00 x 800
Ask0.00 x 1400
Day's range11.23 - 11.79
52-week range5.42 - 16.40
Volume823,899
Avg. volume1,611,538
Market cap1.269B
Beta (5Y monthly)1.51
PE ratio (TTM)14.56
EPS (TTM)0.79
Earnings date30 Jul 2020 - 03 Aug 2020
Forward dividend & yield1.28 (11.12%)
Ex-dividend date13 May 2020
1y target est12.08
  • Hercules Capital (HTGC) Q1 Earnings Beat on Higher Revenues
    Zacks

    Hercules Capital (HTGC) Q1 Earnings Beat on Higher Revenues

    A rise in total investment income supports Hercules Capital's (HTGC) Q1 earnings.

  • Hercules Technology Growth Capital (HTGC) Q1 2020 Earnings Call Transcript
    Motley Fool

    Hercules Technology Growth Capital (HTGC) Q1 2020 Earnings Call Transcript

    Ladies and gentlemen, thank you for standing by, and welcome to the Hercules Capital Q1 2020 earnings conference call. With us on the call today from Hercules are Scott Bluestein, CEO and chief investment officer; and Seth Meyer, CFO. Hercules first-quarter 2020 financial results were released just after today's market close and can be accessed from Hercules Investor Relations section at htgc.com.

  • Hercules Technology (HTGC) Q1 Earnings and Revenues Top Estimates
    Zacks

    Hercules Technology (HTGC) Q1 Earnings and Revenues Top Estimates

    Hercules Tech (HTGC) delivered earnings and revenue surprises of 2.78% and 5.50%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

  • Business Wire

    Hercules Capital Reports First Quarter 2020 Financial Results

    Hercules Capital, Inc. (NYSE: HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced its financial results for the first quarter ended March 31, 2020.

  • Business Wire

    Hercules Capital Declares Cash Distribution of $0.32 per Share for the First Quarter of 2020

    Hercules Capital, Inc. (NYSE: HTGC) ("Hercules" or the "Company"), the largest and leading specialty finance provider to innovative, venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a first quarter 2020 cash distribution of $0.32 per share. The following shows the key dates of the first quarter 2020 distribution payment:

  • Hercules Technology (HTGC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
    Zacks

    Hercules Technology (HTGC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

    Hercules Tech (HTGC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Business Wire

    Hercules Capital Announces Date of 2020 Annual Meeting of Stockholders and Special Meeting of Stockholders

    Hercules Capital, Inc. (NYSE: HTGC) ("Hercules" or the "Company"), will conduct both its 2020 Annual Meeting of Stockholders and its Special Meeting of Stockholders by virtual meeting on Friday, June 12, 2020 at 9:00 a.m. and 10:00 a.m. (Pacific Time), respectively. The proxy statement for each meeting will be mailed separately on or about April 29, 2020 to shareholders of record as of April 20, 2020.

  • Business Wire

    Hercules Capital Announces Date for Release of First Quarter 2020 Financial Results and Conference Call

    Hercules Capital, Inc. (NYSE: HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its first quarter 2020 financial results conference call for Monday, May 4, 2020, at 2:00 p.m. PT (5:00 p.m. ET). Hercules will release its financial results after market close that same day.

  • Business Wire

    Hercules Capital Business and Coronavirus Update

    The team at Hercules Capital, Inc. (NYSE: HTGC) ("Hercules" or the "Company") is working collectively with our employees, shareholders, stakeholders, bondholders, rating agencies, portfolio companies, and our venture capital and private equity sponsors to navigate the significant challenges created by the unprecedented COVID-19 (Coronavirus) pandemic. We are vigilantly monitoring this evolving situation and have implemented actions to keep our employees safe while also managing the continuity of our business. Our thoughts and prayers are with everyone who has been impacted by these events.

  • Hercules Tech (HTGC) Down 49.2% Since Last Earnings Report: Can It Rebound?
    Zacks

    Hercules Tech (HTGC) Down 49.2% Since Last Earnings Report: Can It Rebound?

    Hercules Tech (HTGC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Hercules Capital (HTGC) Q4 Earnings Beat on Higher Revenues
    Zacks

    Hercules Capital (HTGC) Q4 Earnings Beat on Higher Revenues

    Hercules Capital (HTGC) witnesses higher total investment income along with rise in expenses in the fourth quarter of 2019.

  • What's in Store for Hercules Capital (HTGC) in Q4 Earnings?
    Zacks

    What's in Store for Hercules Capital (HTGC) in Q4 Earnings?

    Hercules Capital's (HTGC) results for the fourth quarter of 2019 are expected to reflect favorable impacts of an anticipated rise in investment income.

  • GlobeNewswire

    ChemoCentryx Announces Credit Facility of Up to $100 Million with Hercules Capital

    ChemoCentryx, Inc., (CCXI) today announced that the Company has secured a credit facility of up to $100 million provided by Hercules Capital, Inc. (HTGC), a leader in customized financing for companies in life sciences and technology-related markets. “Through this non-dilutive credit mechanism, we have options to strengthen our robust balance sheet as we advance avacopan towards commercialization in ANCA vasculitis,” said Thomas J. Schall, Ph.D., President and Chief Executive Officer of ChemoCentryx. The $100 million credit facility from Hercules Capital comprises three tranches over the next two years to be drawn at ChemoCentryx’s discretion as follows: the first tranche of $40 million is available through December 2020, $20 million of which would be available upon the submission of the avacopan New Drug Application (NDA) for the treatment of ANCA vasculitis; the second tranche of $30 million is available through December 2021 upon NDA approval of avacopan for the treatment of ANCA vasculitis (NDA Approval); the remaining $30 million is available through December 2022, subject to certain conditions.

  • GlobeNewswire

    Myovant Sciences Announces Closing of $400 Million Loan Facility, Repayment of Debt, Board of Director Transitions, and Executive Promotions

    Low-interest (3-month LIBOR plus 3%) loan facility from Sumitomo Dainippon Pharma increased to allow repayment of pre-existing debtHiroshi Nomura, President, CEO, and.

  • Loan Originations, Solid Liquidity Aid Hercules Capital (HTGC)
    Zacks

    Loan Originations, Solid Liquidity Aid Hercules Capital (HTGC)

    Hercules Capital (HTGC) remains well-positioned for growth based on its strong liquidity position, improving economy and robust loan originations.